Difference between revisions of "WSI21-135"
From MGH Learn Pathology
(Edited automatically from page WSI21-135.) |
|||
| Line 10: | Line 10: | ||
|access=public | |access=public | ||
|subject=MGH | |subject=MGH | ||
| − | |performer= | + | |performer=MGH |
|supportingInfo=Cytology | |supportingInfo=Cytology | ||
|requisition=Cytology | |requisition=Cytology | ||
Revision as of 19:07, July 21, 2022
Request details
Toggle columns: Diagnosis
| Case | Clinical history | Requester | Diagnosis |
|---|---|---|---|
| Case | Clinical history | Requester | Diagnosis |
|
| 71 YO male with h/o gastroesophageal cancer | Ndk6 | Metastatic adenocarcinoma with signet ring features |
|
| 71 YO female with a peritoneal mass | Ndk6 | Poorly differentiated adenocarcinoma |
|
| 76 YO female with a pelvic mass | Ndk6 | Metastatic high-grade serous carcinoma |
|
| Pelvic mass | Td693 | Endometriosis |
|
| 57 YO • uterine neoplasm | Td693 | SMARCA4-deficient undifferentiated uterine sarcoma |
|
| 58 yo f w/ pelvic mass | Ndk6 | Metastatic adenocarcinoma resection dx: High-grade serous carcinoma |
|
| 40 yo f w/ history of gastric adenocarcinoma • w/ signet ring features | Ndk6 | Metastatic adenocarcinoma |
|
| 54 yo f w/ stomach mass | Ndk6 | Metastatic signet ring cell adenocarcinoma consistent with gastric primary |
